Autor: "Matheny KE" - OpacWWW

Skocz do pozycji: 1.

Informacja:: Dostęp do tej pozycji wymaga zalogowania się.

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 2.

Tytuł:: A phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps.
Autorzy:: Kern RC; Northwestern University, Chicago, IL.
Stolovitzky JP; ENT of Georgia, Atlanta, GA.
Silvers SL; Madison ENT & Facial Plastic Surgery, New York, NY.
Singh A; George Washington Medical Faculty Associates, Washington, DC.
Lee JT; Orange County Sinus Institute, Southern California Permanente Medical Group, Irvine, CA.; Department of Head and Neck Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA.
Yen DM; Bethlehem ENT, Bethlehem, PA.
Iloreta AMC Jr; Mount Sinai Hospital, New York, NY.
Langford FPJ; Charlotte Eye ENT Associates, Concord, NC.
Karanfilov B; Ohio Sinus Institute, Dublin, OH.
Matheny KE; Collin County Ear Nose & Throat, Frisco, TX.
Stambaugh JW; Intersect ENT Inc., Menlo Park, CA.
Gawlicka AK; Intersect ENT Inc., Menlo Park, CA.; Pokaż więcej
Corporate Authors:: RESOLVE II study investigators
Źródło:: International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2018 Apr; Vol. 8 (4), pp. 471-481. Date of Electronic Publication: 2018 Jan 19.
Typ publikacji:: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Drug Implants/*therapeutic use
Mometasone Furoate/*therapeutic use
Nasal Mucosa/*drug effects
Nasal Polyps/*therapy
Paranasal Sinuses/*surgery
Sinusitis/*therapy
Adult ; Chronic Disease ; Double-Blind Method ; Female ; Humans ; Male ; Middle Aged ; Nasal Mucosa/physiology ; Nasal Mucosa/radiation effects ; Paranasal Sinuses/drug effects ; Paranasal Sinuses/pathology ; Placebos ; Recurrence

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: RESOLVE: bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis after sinus surgery: 6-month outcomes from a randomized, controlled, blinded study.
Autorzy:: Forwith KD; Advanced ENT and Allergy, Louisville, KY.
Han JK; Divisions of Rhinology and Endoscopic Sinus-Skull Base Surgery and Allergy, Eastern Virginia Medical School, Norfolk, VA.
Stolovitzky JP; ENT of Georgia, Atlanta, GA.
Yen DM; Bethlehem Ear, Nose and Throat Associates, Bethlehem, PA.
Chandra RK; Rhinology, Sinus and Skull Base Surgery, Department of Otolaryngology, Vanderbilt University, Nashville, TN.
Karanfilov B; Department of Otolaryngology, Ohio State University, Ohio Sinus Institute, Dublin, OH.
Matheny KE; Collin County Ear Nose and Throat, Frisco, TX.
Stambaugh JW; Clinical Affairs, Intersect ENT, Menlo Park, CA.
Gawlicka AK; Clinical Affairs, Intersect ENT, Menlo Park, CA.; Pokaż więcej
Źródło:: International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2016 Jun; Vol. 6 (6), pp. 573-81. Date of Electronic Publication: 2016 Mar 14.
Typ publikacji:: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Absorbable Implants*
Anti-Inflammatory Agents/*administration & dosage
Mometasone Furoate/*administration & dosage
Nasal Polyps/*drug therapy
Rhinitis/*drug therapy
Sinusitis/*drug therapy
Ambulatory Care ; Anti-Inflammatory Agents/therapeutic use ; Chronic Disease ; Endoscopy ; Humans ; Mometasone Furoate/therapeutic use ; Nasal Polyps/surgery ; Paranasal Sinuses/surgery ; Patient Reported Outcome Measures ; Recurrence ; Reoperation ; Rhinitis/surgery ; Sinusitis/surgery ; Treatment Outcome